C21 Investments Stock Fundamentals

CXXIF Stock  USD 0.20  0.01  5.26%   
C21 Investments fundamentals help investors to digest information that contributes to C21 Investments' financial success or failures. It also enables traders to predict the movement of C21 OTC Stock. The fundamental analysis module provides a way to measure C21 Investments' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to C21 Investments otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

C21 Investments OTC Stock Operating Margin Analysis

C21 Investments' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current C21 Investments Operating Margin

    
  0.21 %  
Most of C21 Investments' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, C21 Investments is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, C21 Investments has an Operating Margin of 0.214%. This is 100.61% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 103.88% lower than that of the firm.

C21 Investments Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining C21 Investments's current stock value. Our valuation model uses many indicators to compare C21 Investments value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across C21 Investments competition to find correlations between indicators driving C21 Investments's intrinsic value. More Info.
C21 Investments is rated second in return on equity category among its peers. It is number one stock in return on asset category among its peers reporting about  0.62  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for C21 Investments is roughly  1.61 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the C21 Investments' earnings, one of the primary drivers of an investment's value.

C21 Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses C21 Investments' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of C21 Investments could also be used in its relative valuation, which is a method of valuing C21 Investments by comparing valuation metrics of similar companies.
C21 Investments is currently under evaluation in operating margin category among its peers.

C21 Fundamentals

About C21 Investments Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze C21 Investments's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of C21 Investments using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of C21 Investments based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. C21 Investments Inc. was incorporated in 1987 and is headquartered in Vancouver, Canada. C21 Investments is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in C21 OTC Stock

C21 Investments financial ratios help investors to determine whether C21 OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in C21 with respect to the benefits of owning C21 Investments security.